Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Research and Innovation Action · Running

HappyMums Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes

Coordinator
Universita Degli Studi Di Milano, Italy
Runs
1 November 2022 to 31 October 2026
Status
Running
EU funding
€8.9m
Total cost
€8.9m
Partners
17 organisations in 11 countries
Type
Research and Innovation Action
Grant agreement
101057390

What the project is doing

In the project's own words, from its summary on CORDIS.

HappyMums is designed to improve our understanding on the biological mechanisms underlying the development of depressive symptoms in pregnancy, and the efficacy of interventions. It will interrogate a large collection of cohorts with multiple biological, medical, clinical, socio-demographic and environmental and lifestyle data to identify the most robust risk factors triggering depressive symptoms, but also moderators of the risk.

By putting together unique human samples of placenta, chorionic villi and amniotic fluid, and animal models, HappyMums will improve the understanding of the neurobiological mechanisms affected by depressive symptoms in pregnancy that lead to alterations in the foetal environment, shaping offspring risk for developing negative mental outcomes. The use of three complimentary rodent models will allow to achieve a proof of causality, and the presence of an innovative fish model will elucidate the mechanisms specific to placenta by which adverse maternal conditions are transmitted to the offspring without the potentially confounding mitigating effects of compensatory postnatal maternal care.

This knowledge will allow the identification of new targets for the development of novel medications, for the repurposing of existing medications or for the development of non-pharmacological interventions. HappyMums will also develop a digital platform where AI tools-based data can be collected, together with biological, clinical, medical, environmental and lifestyle data, through a mobile phone App that will be at the interface with clinicians via a dedicated dashboard.

This will allow early screening of depressive symptoms, prompt diagnoses, personalized treatments, and the promotion of protective lifestyle attitudes. Overall, HappyMums will not only increase the knowledge in the field of mental disorders in pregnancy, but also improve the wellbeing of these women, providing unprecedented benefits also to the offspring and thus to society at large.

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di MilanoMilanoItalyCoordinator
Universitat ZurichZurichSwitzerlandAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Aarhus UniversitetAarhus CDenmarkParticipant
Universitat De BarcelonaBarcelonaSpainParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Hrvatsko Katolicko SveucilisteZagrebCroatiaParticipant
Ab.acus SRLMilanoItalyParticipant
Ospedale San Raffaele SRLMilanoItalyParticipant
Societa Marce Italiana per La Salute Mentale PerinataleMilanoItalyParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant
Universiteit Van AmsterdamAmsterdamNetherlandsParticipant
Wageningen UniversityWageningenNetherlandsParticipant
Uniwersytet SwpsWarszawaPolandParticipant
King's College LondonLondonUnited KingdomAssociatedpartner
Tommy'sLondonUnited KingdomAssociatedpartner
Trustees of Columbia University in the City of New YorkNew YorkUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI